BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12495547)

  • 1. Physically cross-linked chitosan hydrogels as topical vehicles for hydrophilic drugs.
    Cerchiara T; Luppi B; Bigucci F; Orienti I; Zecchi V
    J Pharm Pharmacol; 2002 Nov; 54(11):1453-9. PubMed ID: 12495547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and partial characterization of hydrogels obtained via glutaraldehyde crosslinking of acetylated chitosan and of hyaluronan derivatives.
    Crescenzi V; Francescangeli A; Taglienti A; Capitani D; Mannina L
    Biomacromolecules; 2003; 4(4):1045-54. PubMed ID: 12857091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan cross-linking with a water-soluble, blocked diisocyanate. 2. Solvates and hydrogels.
    Welsh ER; Price RR
    Biomacromolecules; 2003; 4(5):1357-61. PubMed ID: 12959606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosslinked polyvinylalcohol hydrogels as vehicles for hydrophilic drugs.
    Orienti I; Di Pietra A; Luppi B; Zecchi V
    Arch Pharm (Weinheim); 2000 Dec; 333(12):421-4. PubMed ID: 11199472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
    Panchagnula R; Desu H; Jain A; Khandavilli S
    Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspects of the formation of physical hydrogels of chitosan in a hydroalcoholic medium.
    Boucard N; Viton C; Domard A
    Biomacromolecules; 2005; 6(6):3227-37. PubMed ID: 16283750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-based hydrogels prepared by cross-linking of microbial poly(gamma-glutamic acid) with various saccharides.
    Murakami S; Aoki N
    Biomacromolecules; 2006 Jul; 7(7):2122-7. PubMed ID: 16827578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone.
    He W; Guo X; Zhang M
    Int J Pharm; 2008 May; 356(1-2):82-7. PubMed ID: 18337030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
    Fang JY; Hung CF; Chi CH; Chen CC
    Int J Pharm; 2009 Oct; 380(1-2):33-9. PubMed ID: 19563870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.
    Fang JY; Sung KC; Wang JJ; Chu CC; Chen KT
    J Pharm Pharmacol; 2002 Oct; 54(10):1329-37. PubMed ID: 12396293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linked chitosan/chitin crystal nanocomposites with improved permeation selectivity and pH stability.
    Mathew AP; Laborie MP; Oksman K
    Biomacromolecules; 2009 Jun; 10(6):1627-32. PubMed ID: 19388678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan salts as nasal sustained delivery systems for peptidic drugs.
    Cerchiara T; Luppi B; Bigucci F; Zecchi V
    J Pharm Pharmacol; 2003 Dec; 55(12):1623-7. PubMed ID: 14738587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK; Khandavilli S; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photo-cross-linkable and thermo-responsive hydrogels containing chitosan and Pluronic for sustained release of human growth hormone (hGH).
    Yoo HS
    J Biomater Sci Polym Ed; 2007; 18(11):1429-41. PubMed ID: 17961325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs.
    Lin YH; Liang HF; Chung CK; Chen MC; Sung HW
    Biomaterials; 2005 May; 26(14):2105-13. PubMed ID: 15576185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of chitosan and chitosan/poly(ethylene oxide) beads: a theoretical treatment.
    Martinez L; Agnely F; Leclerc B; Siepmann J; Cotte M; Geiger S; Couarraze G
    Eur J Pharm Biopharm; 2007 Sep; 67(2):339-48. PubMed ID: 17408936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluation.
    Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Calis S; Simonoska M; Hincal AA
    Acta Pharm; 2003 Dec; 53(4):241-50. PubMed ID: 14769231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydration from alcohols by polyion complex cross-linked chitosan composite membranes during evapomeation.
    Uragami T; Yamamoto S; Miyata T
    Biomacromolecules; 2003; 4(1):137-44. PubMed ID: 12523858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil.
    Venuganti VV; Perumal OP
    Int J Pharm; 2008 Sep; 361(1-2):230-8. PubMed ID: 18582550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-covalently cross-linked chitosan based hydrogel.
    Noble L; Gray AI; Sadiq L; Uchegbu IF
    Int J Pharm; 1999 Dec; 192(2):173-82. PubMed ID: 10567748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.